September 18th, 2013
•Receptor tyrosine kinases are ectopically expressed in many cancers and have been identified as therapeutic targets in acute leukemia. This manuscript describes an efficient strategy for pre-clinical evaluation of tyrosine kinase inhibitors for the treatment of acute leukemia.
Video correlati
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
Use of a Low-flow Digital Anesthesia System for Mice and Rats
An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
Pre-clinical Model of Cardiac Donation after Circulatory Death
Invasive Hemodynamic Assessment for the Right Ventricular System and Hypoxia-Induced Pulmonary Arterial Hypertension in Mice